Finance

Lists
PHAR:NASDAQ
Pharming Group NV - ADR
แ‰.แ†แˆย US$
-แ€.แ‰แ‚%
(-แ€.แ€แ‰แ€) 1D
แ€กแ€ฑแ€ฌแ€€แ€บ แ†, GMT-แ„ แแ†:แ€แ€:แ€แ  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
แ‰.แˆแ†ย US$
High
แ‰.แˆแ†ย US$
Low
แ‰.แ†แˆย US$
Mkt. cap
แ†แ‚.แ€แ‰ย แ€€แ€ฏแ€‹แ€ฑ
Avg. vol.
แƒ.แ€แ€ย แ€žแ€ฑแ€ฌแ€„แ€บแ€ธ
Volume
แ†.แ‡แƒย แ€‘แ€ฑแ€ฌแ€„แ€บ
52-wk high
แ‚แ.แƒแ„ย US$
52-wk low
แ‰.แ†แ‚ย US$
Beta
-แ€.แ€แ„
Shares outstanding
แ‡.แ€แˆย แ€€แ€ฏแ€‹แ€ฑ
No. of employees
แ„แ€แ‡
Open
แ‰.แˆแ†ย US$
High
แ‰.แˆแ†ย US$
Low
แ‰.แ†แˆย US$
Mkt. cap
แ†แ‚.แ€แ‰ย แ€€แ€ฏแ€‹แ€ฑ
Avg. vol.
แƒ.แ€แ€ย แ€žแ€ฑแ€ฌแ€„แ€บแ€ธ
Volume
แ†.แ‡แƒย แ€‘แ€ฑแ€ฌแ€„แ€บ
52-wk high
แ‚แ.แƒแ„ย US$
52-wk low
แ‰.แ†แ‚ย US$
Beta
-แ€.แ€แ„
Shares outstanding
แ‡.แ€แˆย แ€€แ€ฏแ€‹แ€ฑ
No. of employees
แ„แ€แ‡
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
แ€•แ€ผแ€ฎแ€ธแ€แ€ฒแ€ทแ€žแ€Šแ€ทแ€บ แ แ€›แ€€แ€บ
Understanding Momentum Shifts in (PHAR)
About Pharming Group NV - ADR
CEO-
Employeesแ„แ€แ‡
Foundedแแ‰แˆแˆ
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to PHAR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current แ‰.แ†แˆย US$
แƒแˆ.แ€แ€ย US$ (+แ‚แ‰แ‚.แ…แ†%)
Average
แƒแ‡.แ…แ€ย US$ (+แ‚แˆแ‡.แ„แ€%)
Lowest
แƒแ‡.แ€แ€ย US$ (+แ‚แˆแ‚.แ‚แƒ%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
แƒแˆ.แ€แ€ย US$
+แ‚แ‰แ‚.แ†%
09/29/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
แƒแ‡.แ€แ€ย US$
+แ‚แˆแ‚.แ‚%
09/30/2026
Jeff Jones
Oppenheimer
Buy
Maintained
แ„แ€.แ€แ€ย US$
+แƒแแƒ.แ‚%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
แ‚แ€แ‚แ… แ€…แ€€แ€บ
แ‚แ€แ‚แ… แ€’แ€ฎ
แ‚แ€แ‚แ† แ€™แ€แ€บ
แ‚แ€แ‚แ† แ€‡แ€ฝแ€”แ€บ
Revenue
แ‰.แ‡แƒย แ€€แ€ฏแ€‹แ€ฑ
แแ€.แ†แ…ย แ€€แ€ฏแ€‹แ€ฑ
แ‡.แ‚แ„ย แ€€แ€ฏแ€‹แ€ฑ
แ‰.แ€แ‚ย แ€€แ€ฏแ€‹แ€ฑ
Cost of goods sold
แ‡.แ€แ‡ย แ€žแ€”แ€บแ€ธ
แ‚.แแย แ€€แ€ฏแ€‹แ€ฑ
แ†.แ†แ„ย แ€žแ€”แ€บแ€ธ
แ.แ„แ…ย แ€€แ€ฏแ€‹แ€ฑ
Cost of revenue
แ‡.แ€แ‡ย แ€žแ€”แ€บแ€ธ
แ‚.แแย แ€€แ€ฏแ€‹แ€ฑ
แ†.แ†แ„ย แ€žแ€”แ€บแ€ธ
แ.แ„แ…ย แ€€แ€ฏแ€‹แ€ฑ
Research and development expenses
แ‚.แแƒย แ€€แ€ฏแ€‹แ€ฑ
แƒ.แ‚แ€ย แ€€แ€ฏแ€‹แ€ฑ
แ‚.แ…แ†ย แ€€แ€ฏแ€‹แ€ฑ
แƒ.แ‚แƒย แ€€แ€ฏแ€‹แ€ฑ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
แ„.แƒแย แ€€แ€ฏแ€‹แ€ฑ
แ….แ€แ‡ย แ€€แ€ฏแ€‹แ€ฑ
แ„.แ…แ…ย แ€€แ€ฏแ€‹แ€ฑ
แ„.แƒแ…ย แ€€แ€ฏแ€‹แ€ฑ
Operating expense
แ†.แ„แƒย แ€€แ€ฏแ€‹แ€ฑ
แˆ.แ‚แ„ย แ€€แ€ฏแ€‹แ€ฑ
แ‡.แ€แ‡ย แ€€แ€ฏแ€‹แ€ฑ
แ‡.แ„แ„ย แ€€แ€ฏแ€‹แ€ฑ
Total operating expenses
แ‡.แแ„ย แ€€แ€ฏแ€‹แ€ฑ
แแ€.แƒแ…ย แ€€แ€ฏแ€‹แ€ฑ
แ‡.แ‡แ„ย แ€€แ€ฏแ€‹แ€ฑ
แˆ.แˆแ‰ย แ€€แ€ฏแ€‹แ€ฑ
Operating income
แ‚.แ…แ‰ย แ€€แ€ฏแ€‹แ€ฑ
แƒ.แ€แƒย แ€žแ€”แ€บแ€ธ
-แ„.แ‰แย แ€žแ€”แ€บแ€ธ
แ.แƒแย แ€žแ€”แ€บแ€ธ
Other non operating income
แ.แˆแˆย แ€žแ€”แ€บแ€ธ
แ„.แ€แƒย แ€žแ€ญแ€”แ€บแ€ธ
-
-แƒ.แ‚แ€ย แ€žแ€ฑแ€ฌแ€„แ€บแ€ธ
EBT including unusual items
แ.แ‚แˆย แ€€แ€ฏแ€‹แ€ฑ
แ„.แˆแ€ย แ€žแ€”แ€บแ€ธ
-แ„.แ‡แ…ย แ€žแ€”แ€บแ€ธ
แƒ.แ€แ„ย แ€žแ€”แ€บแ€ธ
EBT excluding unusual items
แ‚.แ‚แ‰ย แ€€แ€ฏแ€‹แ€ฑ
แ.แ†แย แ€žแ€”แ€บแ€ธ
-แ„.แ‡แ…ย แ€žแ€”แ€บแ€ธ
แƒ.แ€แ„ย แ€žแ€”แ€บแ€ธ
Income tax expense
แ….แ‚แย แ€žแ€”แ€บแ€ธ
-แ….แ‚แˆย แ€žแ€ญแ€”แ€บแ€ธ
แ„.แ…แ‰ย แ€žแ€ญแ€”แ€บแ€ธ
แ.แ„แ€ย แ€žแ€”แ€บแ€ธ
Effective tax rate
แ„แ€.แˆแƒ%
-แแ.แ€แ€%
-แ‰.แ†แ…%
แ„แ†.แแ‚%
Other operating expenses
-แ‡.แแ€ย แ€žแ€ฑแ€ฌแ€„แ€บแ€ธ
-แƒ.แ„แˆย แ€žแ€ญแ€”แ€บแ€ธ
-แƒ.แ‡แ‡ย แ€žแ€ญแ€”แ€บแ€ธ
-แ.แ„แ‚ย แ€žแ€”แ€บแ€ธ
Net income
แ‡.แ…แ…ย แ€žแ€”แ€บแ€ธ
แ….แƒแƒย แ€žแ€”แ€บแ€ธ
-แ….แ‚แย แ€žแ€”แ€บแ€ธ
แ.แ†แ„ย แ€žแ€”แ€บแ€ธ
Net profit margin
แ‡.แ‡แ†%
แ….แ€แ€%
-แ‡.แ‚แ€%
แ.แˆแ‚%
Earnings per share
แ€.แ€แ
แ€.แ€แ
-แ€.แ€แ‡
แ€.แ€แ€
Interest and investment income
-
แ„.แ…แ€ย แ€žแ€”แ€บแ€ธ
แƒ.แ‚แ„ย แ€žแ€”แ€บแ€ธ
-
Interest expense
-แ‰.แ‚แย แ€žแ€”แ€บแ€ธ
-
-แ‚.แ‡แ€ย แ€žแ€”แ€บแ€ธ
-แ„.แแ€ย แ€žแ€”แ€บแ€ธ
Net interest expenses
-แ‰.แ‚แย แ€žแ€”แ€บแ€ธ
แ„.แ…แ€ย แ€žแ€”แ€บแ€ธ
แ….แ„แ‚ย แ€žแ€ญแ€”แ€บแ€ธ
-แ„.แแ€ย แ€žแ€”แ€บแ€ธ
Depreciation and amortization charges
-
-
-
-
EBITDA
แƒ.แ€แย แ€€แ€ฏแ€‹แ€ฑ
แ†.แ‚แ„ย แ€žแ€”แ€บแ€ธ
-แ.แˆแ€ย แ€žแ€”แ€บแ€ธ
แ‚.แ†แ‡ย แ€žแ€”แ€บแ€ธ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google แ€กแ€€แ€บแ€•แ€บแ€™แ€ปแ€ฌแ€ธ